Quotient Ltd (NASDAQ:QTNT) traded up 8.3% on Wednesday . The company traded as high as $9.53 and last traded at $9.26. 684,700 shares changed hands during trading, an increase of 97% from the average session volume of 347,725 shares. The stock had previously closed at $8.55.
Several brokerages recently issued reports on QTNT. Zacks Investment Research raised Quotient from a “sell” rating to a “hold” rating in a research report on Wednesday, May 8th. BidaskClub raised Quotient from a “sell” rating to a “hold” rating in a research report on Tuesday, May 7th. Finally, ValuEngine lowered Quotient from a “strong-buy” rating to a “buy” rating in a research report on Friday, April 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. Quotient currently has a consensus rating of “Hold” and an average target price of $11.75.
The stock has a market cap of $594.38 million, a PE ratio of -4.52 and a beta of 1.25. The company has a debt-to-equity ratio of 4.95, a current ratio of 6.87 and a quick ratio of 6.05.
Large investors have recently made changes to their positions in the stock. Lombard Odier Asset Management USA Corp lifted its position in shares of Quotient by 4.0% in the first quarter. Lombard Odier Asset Management USA Corp now owns 260,000 shares of the company’s stock valued at $2,343,000 after acquiring an additional 10,000 shares in the last quarter. Morgan Stanley lifted its position in shares of Quotient by 151.1% in the first quarter. Morgan Stanley now owns 1,772,678 shares of the company’s stock valued at $15,972,000 after acquiring an additional 1,066,682 shares in the last quarter. M&T Bank Corp lifted its position in shares of Quotient by 113.6% in the first quarter. M&T Bank Corp now owns 21,829 shares of the company’s stock valued at $197,000 after acquiring an additional 11,609 shares in the last quarter. SEI Investments Co purchased a new position in shares of Quotient in the first quarter valued at approximately $680,000. Finally, Essex Investment Management Co. LLC purchased a new position in shares of Quotient in the first quarter valued at approximately $1,152,000. 66.32% of the stock is currently owned by institutional investors.
Quotient Company Profile (NASDAQ:QTNT)
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.
Featured Story: How Important is Technical Analysis of Stocks
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.